metastatic melanoma
melanoma incidence
skin cancer Melanoma
metastasis of human malignant melanoma cells
specific drug
cancer cells
Europe
year survival rate
patients
urgent need of new treatment options
market assessment
market strategy
specific protein
lead optimization
potential collaborators
commercial opportunity
commercial activities
lead molecule
Potential Chemopreventive Agent
preclinical verification
IPR positioning
inhibitors
proliferation
disease
concept proposal
serious health problem
foundation stone of precision medicine
regions
current clinical therapies
low efficacy
high number of Caucasians
development of novel drugs
dialogue
inhibition
fastest growing cancers
significant adverse events
present proof
Discovery of Bcl
Molecular targeted therapy
increase
growth
deaths
societal concern
diagnoses